[Featured Stock] Intromedic Rises on Participation in Cyworld Cryptocurrency Issuance Based on Metaverse
[Asia Economy Reporter Jang Hyowon] Intromedic, a company specializing in capsule endoscopy, is showing strong performance as it is known to be a key investor in the revival of Cyworld.
As of 9:51 AM on the 18th, Intromedic's stock price is trading at 2,430 KRW, up 6.81% compared to the previous trading day.
The news that Cyworld plans to list and use cryptocurrency instead of 'Dotori' appears to be influencing the stock price as well.
Cyworld is expected to transform by leveraging the Metaverse and cryptocurrency, and Intromedic is a major investor in Cyworld Z, a newly established corporation that acquired the service operation rights of Cyworld. Intromedic is expected to provide various development and operational funding following the service resumption.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "I Take Full Responsibility"... Chung Yongjin Issues Direct Apology for Starbucks 'May 18 Controversy' (Update)
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Meanwhile, the U.S. online gaming company 'Roblox' saw its stock price rise more than 54% above the reference price on its direct listing debut on the New York Stock Exchange, becoming a company valued at $45.2 billion (approximately 51.32 trillion KRW).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.